Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Malignant neoplasms evolve in response to changes in oncogenic signalling. Cancer cell plasticity in response to evolutionary pressures is fundamental to tumour progression and the development of therapeutic resistance. Here we determine the molecular and cellular mechanisms of cancer cell plasticity in a conditional oncogenic Kras mouse model of pancreatic ductal adenocarcinoma (PDAC), a malignancy that displays considerable phenotypic diversity and morphological heterogeneity. In this model, stochastic extinction of oncogenic Kras signalling and emergence of Kras-independent escaper populations (cells that acquire oncogenic properties) are associated with de-differentiation and aggressive biological behaviour. Transcriptomic and functional analyses of Kras-independent escapers reveal the presence of Smarcb1-Myc-network-driven mesenchymal reprogramming and independence from MAPK signalling. A somatic mosaic model of PDAC, which allows time-restricted perturbation of cell fate, shows that depletion of Smarcb1 activates the Myc network, driving an anabolic switch that increases protein metabolism and adaptive activation of endoplasmic-reticulum-stress-induced survival pathways. Increased protein turnover renders mesenchymal sub-populations highly susceptible to pharmacological and genetic perturbation of the cellular proteostatic machinery and the IRE1-α-MKK4 arm of the endoplasmic-reticulum-stress-response pathway. Specifically, combination regimens that impair the unfolded protein responses block the emergence of aggressive mesenchymal subpopulations in mouse and patient-derived PDAC models. These molecular and biological insights inform a potential therapeutic strategy for targeting aggressive mesenchymal features of PDAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prior studies using inducible suppression of KRAS via RNA interference or genetically engineered inducible KrasG12D alleles (i.e., “iKras” model) have suggested that amplification of YAP1 or induction of an epithelial-to-mesenchymal transition (EMT) can confer a state of RAS independence and overcome KRASG12D suppression (35–38).”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, studies of the iKras mouse model have highlighted myriad mechanisms to enable bypass of oncogenic KRAS addiction, including the adoption of a KRAS-independent cell state dependent on oxidative phosphorylation (5), induction of SMARCB–MYC-network-driven mesenchymal reprogramming (38), activation of the TGFβ-SMAD3/4 axis via TME remodeling (39), and USP21-mediated upregulation of macrop”
From Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,890
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Self-citationUrano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 2,988
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citationEMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136 · cited 1×
“The prominent cellular plasticity of PDAC has fueled speculation that these properties may contribute to its aggressive clinical behaviour 4–6 .”
Self-citationSubtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2344 · Cited by 1,967
Research works printed but not linked: 1
- Lee CL et al. Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice. Dis. Model. Mech 5, 397–402 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
Cited by
Items 101–132 of 132
Waldron, R. T., Lugea, A., Chang, H.-H., Su, H., Quiros, C., Lewis, M. S., Che, M., Ramanujan, V. K., Rozengurt, E., Eibl, G., et al. (2024) · Cancers · doi:10.3390/cancers16081593 · Cited by 3
Intratumor heterogeneity in KRAS signaling shapes treatment resistance
Petrenko, O., Kirillov, V., D’Amico, S., & Reich, N. C. (2024) · iScience · doi:10.1016/j.isci.2024.111662 · Cited by 4
Kotagiri, S., Wang, Y., Han, Y., Liang, X., Blazanin, N., Nguyen, P. K., Jiang, Y., & Lissanu, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.23.608456 · Cited by 3
Road Map to Defeat Pancreatic Cancer
Ferguson, L. P., & Tuveson, D. A. (2025) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060624-044323 · Cited by 3
The Unfolded Protein Response in Triple-Negative Breast Cancer
Zhao, N., Peng, F., & Chen, X. (2019) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-05067-2_7 · Cited by 2
9p21 Loss Defines the Evolutionary Patterns of Aggressive Renal Cell CarcinomasPreprint
Carbone, F., Huang, J. K.-L., Perelli, L., Poggetto, E. D., Gutschner, T., Tomihara, H., Soeung, M., Lam, T., Xia, R., Zhu, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.03.367433 · Cited by 3
Self-citationPerelli, L., & Genovese, G. (2025) · Journal of Clinical Investigation · doi:10.1172/jci193205 · Cited by 1
Self-citationEvans, J. R., Wang, J., Reed, C. N., Creighton, J. H., Garrison, K. B., Robertson, A. N., Lira-Rivera, A., Baisden, D. D., Tansey, W. P., Al-Tobasei, R., et al. (2025) · Cancers · doi:10.3390/cancers17132255 · Cited by 1
RAS Pathway Activation and Microenvironmental Adaptation as Hallmarks of Myeloid Sarcoma
Nadorp, B., Lasry, A., Loghavi, S., Patel, R., Mansour, H. M., Kelly, B., Walker, C. J., Buss, J., Boateng, I., Al-Santli, W., et al. (2026) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-26-0160 · Cited by 5
Apoptosis: Signaling Pathways in Pancreatic Cancer Pathogenesis
McConkey, D. J., & Choi, W. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_14-2 · Cited by 4
RETRACTED ARTICLE: SNF5 promotes cell proliferation and immune evasion in non-small cell lung cancer
Chen, Y., Zhao, M., Shen, D., Yi, Q., & Tang, L. (2022) · Bioengineered · doi:10.1080/21655979.2022.2068894 · Cited by 1
RetractedPapers of note in Nature 542 (7641)
VanHook, A. M. (2017) · Science Signaling · doi:10.1126/scisignal.aam9984
Role of Epigenetic Regulation of Growth Arrest States in Normal and Cancer Cells
Wille, J. J. (2017) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100047 · Cited by 1
p97/VCP induces GLI1 to control XBP1-dependent endoplasmic reticulum stress transcriptional responsePreprint
Barroso, K., Almada, L. L., Olson, R., Auner, H. W., Pedeux, R., Iovanna, J., Chevet, É., & Fernández-Zapico, M. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.24.432555
Targeting SWI/SNF metabolic vulnerabilities in cancer
Soeung, M., Perelli, L., Sgambato, A., & Genovese, G. (2021) · Annals of Research in Oncology · doi:10.48286/aro.2021.31
Self-citationShay, J. W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735914525.793561960
Tomihara, H., Carbone, F., Perelli, L., Huang, J. K.-L., Soeung, M., Rose, J. L., Robinson, F. S., Deribe, Y. L., Feng, N., Takeda, M., et al. (2023) · doi:10.1158/0008-5472.c.6512376.v1
Self-citationData from HDAC2 Facilitates Pancreatic Cancer Metastasis
Krauß, L., Urban, B. C., Hastreiter, S., Schneider, C., Wenzel, P., Hassan, Z., Wirth, M., Lankes, K., Terrasi, A., Klement, C., et al. (2023) · doi:10.1158/0008-5472.c.6513666
Nguyen, A., Leydecker, A. K., Mustafa, A. M., Murr, J., Butter, F., & Krämer, O. H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.03.556106
Systemic Therapies for Advanced Non-Clear Cell Renal Cell Carcinoma
Mendhiratta, N., Noun, J., Daneshvar, M., & Srinivasan, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-40901-1_16
KRAS-driven cancer models for in vivo pharmacology and drug discovery
Chugh, S., Dow, L. E., Singh, M., & Aguirre, A. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21861-3.00004-8
Chen, X., Keller, S. J., Das, T., Hafner, P., Alrawashdeh, A. Y., Jumaa, H., Chen, T., Besson, S., Norona, J., Schneider, M., et al. (2025) · medRxiv · doi:10.1101/2025.09.09.25335395
Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcomaPreprint
Nadorp, B., Lasry, A., Loghavi, S., Patel, R., Mansour, H. M., Kelly, B., Walker, C. J., Buss, J. L., Boateng, I., Al-Santli, W., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.04.689069
Nguyen, A., Mustafa, A.-H. M., Leydecker, A. K., Halilovic, M., Murr, J., Butter, F., & Krämer, O. H. (2024) · Figshare · doi:10.6084/m9.figshare.25538505
Qian, Y., Yan, Z., Wang, J., An, Q., Luo, J., Mutailifu, M., Tulamaiti, A., Zhang, X.-L., Zhang, Z.-G., & Li, D. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08613-4
The anti-tumoral effects of a low protein diet and of the IRE1α signaling
Turtos, A. M. (2022) · theses.fr (ABES) · doi:10.70675/fd90a3e8ze35az42fdzbd0ez966f12ddad22
Yu, K., Tidwell, R. S. S., Bathala, T. K., Sheth, R. A., Karki, M., Chen, J., Qian, J., Duan, F., Perelli, L., Soeung, M., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-4518 · Cited by 2
Self-citationLi, R., Xu, X., Zhang, W., & Zhan, Y.-Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1843505
Li, J., 阙日升, Zhang, J., Ma, K., Guo, S., Wen, L., Zhao, J., Chen, W., Wang, X., Qin, H., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218797
Self-citationJiang, Y., Pagen, C., Yin, G., Zhang, Z., Wang, M., Poltorack, C. D., Xue, Y., Han, X., Coffey, N. J., Brown, M., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2612523123
Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions
Ren, Y., Yang, L., Fei, B., Guo, R., Huang, J., Xu, Z., Wang, R., Zhang, P., Cao, D., Chen, P., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3356-1
Metadata
- Authors
- Genovese, G., Carugo, A., Tepper, J., Robinson, F. S., Li, L., Svelto, M., Nezi, L., Corti, D., Minelli, R., Pettazzoni, P., Gutschner, T., Wu, C.-C., Seth, S., Akdemir, K. C., Leo, E., Amin, S., Molin, M. D., Ying, H., Kwong, L. N., Colla, S., Takahashi, K., Ghosh, P., Giuliani, V., Muller, F., Dey, P., Jiang, S., Garvey, J., Liu, C.-G., Zhang, J., Heffernan, T. P., Toniatti, C., Fleming, J. B., Goggins, M. G., Wood, L. D., Sgambato, A., Agaimy, A., Maitra, A., Roberts, C. W. M., Wang, H., Viale, A., DePinho, R. A., Draetta, G. F., & Chin, L.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Università Cattolica del Sacro Cuore (IT)
- Johns Hopkins University (US)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Genovese, Giannicola
- Draetta, Giulio F.
- ORCID
- Genovese, Giannicola
- Carugo, Alessandro
- Robinson, Frederick Scott
- Svelto, Maria
- Nezi, Luigi
- Corti, Denise
- Pettazzoni, Piergiorgio
- Gutschner, Tony
- Wu, Chia-Chin
- Seth, Sahil
- Akdemir, Kadir Caner
- Leo, Elisabetta
- Amin, Samirkumar
- Molin, Marco Dal
- Ying, Haoqiang
- Kwong, Lawrence N.
- Colla, Simona
- Takahashi, Koichi
- Giuliani, Virginia
- Dey, Prasenjit
- Jiang, Shan
- Zhang, Jianhua
- Heffernan, Timothy P.
- Toniatti, Carlo
- Fleming, Jason B.
- Goggins, Michael G.
- Wood, Laura D.
- Sgambato, Alessandro
- Agaimy, Abbas
- Maitra, Anirban
- Roberts, Charles W. M.
- Wang, Huamin
- Viale, Andrea
- DePinho, Ronald A.
- Draetta, Giulio F.
- Venue
- Nature
- Published
- 2017-02-08
- Volume
- 542
- Issue
- 7641
- Pages
- 362-366
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7609022
- OpenAlex
- W2586537166
- Cited by
- 131
- References
- 58
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 8 · 2023: 16 · 2022: 14 · 2021: 15 · 2020: 17 · 2019: 17 · 2018: 11 · 2017: 11
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-08-17)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R00CA218891, U01CA141508, K99CA218891, P50CA062924, P30CA016672)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- pancreatic ductal adenocarcinoma, SMARCB1, tumor plasticity, protein metabolism, endoplasmic reticulum stress response, unfolded protein response, MAPK signaling, dedifferentiation, proteostasis
- MeSH terms
- SMARCB1 Protein, Gemcitabine, Animals, Deoxycytidine, Female, Humans, Male, Mesoderm, Mosaicism, Pancreatic Neoplasms, Genes, ras, Genes, myc, Oncogene Protein p55(v-myc), Proto-Oncogene Proteins p21(ras), MAP Kinase Signaling System, Carcinoma, Pancreatic Ductal, MAP Kinase Kinase 4, Mice, Transcriptome, Proteolysis, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.